Teprotumumab for Inactive Thyroid Eye Disease? The Jury Is Still Out.

Journal Article Accepted manuscript "Teprotumumab for inactive thyroid eye disease? The jury is still out." Get access Chrysoula Dosiou, MD, MS Chrysoula Dosiou, MD, MS Division of Endocrinology, Stanford University School of Medicine, Stanford, CA Correspondence and reprint requests: Chrysoula Dosiou, MD, MS, Division of Endocrinology, Stanford University School of Medicine, 300 Pasteur Drive, S025, Stanford, CA 94305, Email: cdosiou@stanford.edu https://orcid.org/0000-0001-6609-5135 Search for other works by this author on: Oxford Academic Google Scholar The Journal of Clinical Endocrinology & Metabolism, dgae052, https://doi.org/10.1210/clinem/dgae052 Published: 27 January 2024 Article history Received: 11 December 2023 Revision received: 19 January 2024 Accepted: 23 January 2024 Published: 27 January 2024